Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dymista in Chinese Adolescents With Allergic Rhinitis
NCT07597473Phase 4Completed
- Sponsor
- Viatris
- Start
- May 2026
- Primary completion
- Sep 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of azelastine, fluticasone propionate nasal spray in allergic rhinitis (AR), sponsored by Viatris. Started May 2026; status: completed.
02
Drugs
azelastinefluticasone propionate nasal spray
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT07597473.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07597473.